CRM Shorts Retreat as Peers Slide

Salesforce stands out in enterprise software this week, but not in the way it did a week ago: short interest has dropped sharply, reversing the month-long build that defined the previous note, even as the stock slipped while several peers held gains.

Among its closest correlated peers, NOW added 3.5% over the past week and WK climbed 6.5%. NCNO rose 6.1%. Salesforce fell 0.6% over the same stretch to $240.89, lagging the peer median of roughly +1.1%. ADBE and PEGA also dropped, down 3.3% and 2.5% respectively, so the underperformance is not universal, but Salesforce is on the wrong side of a split week.

The short interest story has changed materially since the October 21 note flagged a 34% monthly build. Short interest has now dropped 18% over the past week, falling to 3.05% of free float from a peak above 3.7%. The shares outstanding that were building from late September through mid-October have come off quickly: the move from roughly 38 million shorted shares on October 7 to just under 29 million today is a genuine unwind, not noise. The borrow market reflects a name that was never under pressure from the short side in structural terms. Availability is approximately 2,371% of short interest, meaning shares available to borrow dwarf those currently lent out by a factor of more than 20. Cost to borrow is 0.41%, down 18% on the week and still firmly in low-cost territory. The short score has also eased, dropping from 37.5 on October 22 to 35.2 today, its lowest reading in the observed window.

Options positioning is steady but mildly defensive. The put/call ratio is 0.965, just above its 20-day mean of 0.959 and roughly half a standard deviation above that average. The 52-week range on the PCR runs from 0.58 to 1.20, placing the current reading in the middle of its historical band. Options traders are not expressing strong directional conviction either way ahead of the December 2 earnings date.

The analyst picture shifted earlier in October when BofA Securities upgraded Salesforce to Buy from Underperform, lifting its target to $285 from $160. That is the most significant directional change in the recent analyst log, and it moved the consensus further toward a bullish lean. DA Davidson raised its target to $250 this week while keeping a Neutral rating, and Cantor Fitzgerald reiterated Overweight at $300. The consensus target of $287 implies roughly 19% upside from the current price, a gap that reflects the AI growth angle more than the current multiple. The PE at 14.9 and EV/EBITDA at 10.3 are not stretched for a $198 billion enterprise software company, and both have drifted lower over the past 30 days as the stock underperformed its peers. The analyst recommendation score ranks in the 97th percentile of the ORTEX universe, reflecting broad coverage tilted toward positive ratings despite pockets of skepticism on execution.

The bear case centers on Informatica integration risk, legacy marketing cloud attrition, and the question of whether Agentforce ramps fast enough to matter for near-term margins. The bull case rests on Agentforce and Data ARR hitting $3.9 billion, up 210% year over year, accelerating cRPO growth of 14% in Q2, and a platform that management argues spans the full enterprise AI stack. That tension is unresolved. At the last earnings print in September, the stock fell 5% on the day and 7% over the following week. The prior print in August produced a 22% one-day gain. The range of outcomes around the December 2 report is wide.

The level that would change the positioning picture is whether short interest resumes building toward the 3.5% to 3.7% range seen through most of October, or continues fading toward the late-September lows around 2.7% of float.